European Sleep Apnea Therapeutic Devices Market
- Report Code: SL 1002
- Publish Date: Upcoming
The European Sleep Apnea Therapeutic Devices Market is mainly driven by enormous patient base of Obstructive Sleep Apnea (OSA) accompanied by technological amelioration of well designed Positive Airway Pressure (PAP) devices and oral appliances worldwide. The market was valued at $1.7 billion in 2013 and is expected to reach $3.6 billion in 2018, at a CAGR of 16.5%. The Positive Airway Pressure (PAP) devices market constitutes the largest segment of this market.
The report “European Sleep Apnea Therapeutic Devices Market forecast, 2012-2018” analyzes the market of devices by 7 segments such as PAP Devices, Facial Interfaces, Adaptive Servo Ventilation, Airway Clearance Systems, Oxygen Devices, Accessories and Oral Appliances. All these segments experience a substantial positive growth owing to the elevated momentum in the awareness levels among the care givers and patients. CPAP devices segment has been contributing majorly in terms of value towards the total European industry. In terms of volume (units), CPAP devices segment holds a prime stand in Europe. The market has been witnessing the maximum growth because of increase in patient pool and rise in incidences of Obstructive Sleep Apnea (OSA). Oral Appliances constitute the fastest growing market at a CAGR of 15% from 2013-2018.
Germany accounted for the largest market share in this market. This is chiefly attributed to the increasing healthcare awareness for sleep apnea, rising disposable incomes, improving healthcare infrastructure, economic growth favored by broadening insurance coverage and increasing obesity adding to the pool of sleep apnea patients. According to The European Sleep Apnea Database (ESADA), by March 2014, the number of enrolled patients reached 15,956 along with 5313 follows up visits.
The report also provides a detailed competitive landscaping of Companies operating in this market. Segment and Country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies would be detailed. The main companies operating in this market in Europe are ResMed, Inc., Philips Respironics, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Carefusion, Corp., Weinmann Medical Devices, BMC Medical Co. Ltd., Curative Medical, Inc. and other companies.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Country specific Prevalence of Obstructive Sleep Apnea (OSA)
- Country specific Patient pool of Obstructive Sleep Apnea (OSA)
- Disease progression (Pattern analysis)
Ancillary Data
- Number of unit sales along with the respective ASPs annually in each country tracked till sub-segment level, number of surgeries.
- Usage data and purchasing data
- Number of hospitals, number of home healthcare units and number of clinics.
- Healthcare expenditure across major geographies
Surgeons/Physicians perception analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Pattern analysis of usage of Sleep apnea therapeutic devices by physicians
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Competitive Intelligence
- Company share analysis of the key players, forecast till 2018, across the sub-segments, country-wise
- Develop business strategies to enhance the bottom line of the companies
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Asian Sleep Apnea Devices The Sleep Apnea Devices market in Asia has been slated to gather pace in the coming years as a result of the awareness levels of Sleep Apnea. The market is clinched at $1.4 billion in 2013 and is expected to reach a value of $3.1 billion in 2018, with a CAGR of 17.5% from 2013-2018. The market has been segmented on the basis of Products, Geographies (Japan, China, India), Endusers, Companies and Macroindicator. The main companies operating in the market are Philips Respironics, ResMed, Inc., Fisher & Paykel Healthcare, Carefusion, Corp., DeVilbiss Healthcare, Weinmann Medical Devices, BMC Medical Co. Ltd., Natus Medical, Inc., Compumedics, Ltd., Nihon Kohden Corporation and other companies. Deep dive analysis of the key players have been considered in this report. |
Upcoming |
|
|
Discount Link - Medical Terminology Software Market by Application (Data Aggregation, Reimbursement, Decision Support, Clinical Trials), Product & Service (Services and Platforms), End User (Healthcare Provider, Payer, IT Vendor) - Global Forecast to 2024 Discount Link - Medical Terminology Software Market by Application (Data Aggregation, Reimbursement, Decision Support, Clinical Trials), Product & Service (Services and Platforms), End User (Healthcare Provider, Payer, IT Vendor) - Global Forecast to 2024 |
Mar 2019 |
|
|
European Sleep Apnea Devices The European sleep apnea devices market is expected to grow at a CAGR of 16.0% from 2014 to 2019. This growth of devices market is attributed to the increasing patient pool of sleep apnea patients, increase in the prevalence of comorbidities associated with sleep apnea, as well as the elevated levels of awareness among patients and caregivers. |
Feb 2015 |
